Clinical Trials Logo

Filter by:
NCT ID: NCT01638208 Not yet recruiting - Clinical trials for Irritable Bowel Syndrome

Changes in Gastrointestinal Microbiota Using VSL#3 in Patients With IBS-D

Start date: August 2012
Phase: Phase 4
Study type: Interventional

Aim To compare changes in gut microbiota of IBS patients and healthy controls using next generation sequencing method like Illumina sequencing based on 16S rDNA profiling. The major objectives of the study are: To characterize type of bacterial species and compare diversity of the host's gut microbiota in 20 Irritable bowel syndrome (IBS) patients with 16 healthy controls (HCs) using high through put culture-independent method like Illumina sequencing. To study modulation of gut microbiota profile after treatment with probiotics (VSL #3) for 8 weeks. To study the improvement of symptoms after modulation of gut microbiota with probiotics (VSL #3) for more than 8 weeks.

NCT ID: NCT01566552 Not yet recruiting - Clinical trials for Visceral Leishmaniasis

Single Dose Liposomal Amphotericin B for Visceral Leishmaniasis

Start date: June 2014
Phase: Phase 4
Study type: Interventional

The study is designed to determine the use of delivering point of care, rapid diagnosis with rK39 and treatment with AmBisome single dose of 10 mg/kg when administrated in the Primary Health Center (PHC) settings with regard to operational feasibility, safety and final cure rate at 6 months after end of treatment. Point of care diagnosis and treatment (PCDT) at the PHC level would bring the best available interventions closer to the patients with visceral leishmaniasis (VL) whose villages are within several kilometers of the PHC. This would support the VL elimination program in the Indian subcontinent.

NCT ID: NCT01536106 Not yet recruiting - Clinical trials for Acute Myocardial Infarction

Rapid Delivery of Autologous Bone Marrow Derived Stem Cells in Acute Myocardial Infarction Patients.

AMIRST
Start date: December 2013
Phase: Phase 1/Phase 2
Study type: Interventional

The primary objective of the study is to determine the feasibility and safety of intracoronary administration of autologous bone marrow derived mononuclear cell product in patients at risk for clinically significant cardiac dysfunction following AMI. The secondary objective of the study is to assess the effect on cardiac function and infarct region perfusion. A concurrent placebo control patient group meeting eligibility but not receiving autologous bone marrow derived stem cells will be evaluated similar to the treated group to assess the rate of significant spontaneous improvement in cardiac function.

NCT ID: NCT01476670 Not yet recruiting - Brain Tumor Clinical Trials

Cerebral Blood Circulation in Patients With Posterior Fossa Brain Tumor

Start date: July 2012
Phase: N/A
Study type: Observational

The normal cerebral blood flow is guided by factors such as cerebral autoregulation (CA) and carbon dioxide reactivity (CO2R). Authors have demonstrated that CA and CO2R may be impaired in presence of intracranial tumors.Most studies pertaining to assessment of CA and CO2R in patients with brain tumors is limited to supratentorial tumors. Due to their anatomic location, posterior fossa tumors result in obstruction of ventricular outflow, produce hydrocephalus and features of raise intracranial pressure (ICP). It is possible that lesions in the posterior fossa may affect CA and CO2R. It should also be noted that posterior fossa surgeries are carried out in positions such as prone, lateral and sitting. Altered surgical positions themselves affect systemic hemodynamics which may influence cerebral blood flow; with presence of anesthetics further compromising the blood flow to the brain. Understanding the homeostatic mechanisms of CA and CO2R may help in deciding proper positioning of patients and maintenance of intraoperative hemodynamic. The aim of this observational study was to evaluate CA and CO2R in patients with posterior fossa tumor prior to surgical decompression of the lesion.

NCT ID: NCT01351701 Not yet recruiting - Diabetic Foot Clinical Trials

Bacteriological Study of Diabetic Foot and Antibiotic Sensitivity Pattern in Eastern India

Start date: June 2011
Phase: N/A
Study type: Observational

The pattern of organism causing diabetic foot infection are presumed to vary from location to location depending on the antibiotic prescription practice, geographical locations, environmental variations and therapeutic interventions for various patients. Our hypothesis is look to finding out common similarities with diversified subgroups spread across various geographical locations of eastern part of India, thus to create a data base for treating patient with diabetic foot infections.The sensitivity pattern is anticipated to be different from institution to institutions and place to place but the gross sensitivity data of local pathogen could guide physician for choosing right empirical antibiotic. Practice guideline could be postulated from the collated data of distribution of pathogens, their sensitivity pattern as well as co-morbid conditions of the sufferers.

NCT ID: NCT01246154 Not yet recruiting - To Evaluate Clinical Trials

An Evaluation of Exercise Tolerance in Asthmatic Patients

Start date: November 2010
Phase: N/A
Study type: Observational

To evaluate exercise tolerance.

NCT ID: NCT01178736 Not yet recruiting - Breast Neoplasms Clinical Trials

Early Detection of Cancers in Low Resource Countries

Start date: March 2011
Phase: Phase 0
Study type: Observational

The purpose of this study is to implement a community-based combined program for early detection of breast, cervical, ovarian and endometrial cancer in low-resource countries delivered through a free standing or a mobile Well Woman Clinic. The goals of this program are to downstage cancers and improve mortality rates using low-cost early detection methods. These programs will be implemented in regions where early cancer detection strategies are not in place and cancers present at advanced stages with resultant high mortality. Currently, there are three target project sites: Cambodia (June 2011), India (June 2011), and Brazil (March 2011). Memorandums of Understanding have been secured with local health organizations in each region to establish clinic operations. Each clinic would serve an approximate target population of 100,000 amongst whom about 12,000 eligible women (4-5,000 annually) will be invited to be screened for breast and cervical cancer over a three-year time span.

NCT ID: NCT00980421 Not yet recruiting - Oxidative Stress Clinical Trials

Safety of Various Mode of Delivery of Iron Supplement on Iron Toxicity Markers in Preschool Children

Start date: October 2009
Phase: Phase 3
Study type: Interventional

The purpose of study is to evaluate and compare the effect of iron supplementation when given as iron tablet or fortified biscuit or combined with zinc in the form of tablet on morbidity and iron toxicity markers among children aged 24-36 months.

NCT ID: NCT00922389 Not yet recruiting - Diabetic Foot Clinical Trials

A Clinical Trial on Diabetic Foot Using Peripheral Blood Derived Stem Cells for Treating Critical Limb Ischemia

Start date: July 2009
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to determine whether the method (implanting stem cells derived from peripheral blood after G-CSF mobilization) of treatment is safe and effective in the management of diabetic foot ischemia, the therapeutic effect of stem cells is caused by improving blood circulation in ischemic limb which would in turn promote ulcer healing, prevent amputation of limb and relieve the Sevier pain of ischemia.

NCT ID: NCT00902967 Not yet recruiting - Abdominal Surgery Clinical Trials

Study To Check The Analgesic And Anti-Inflammatory Effects Of Atorvastatin In Patients Undergoing Abdominal Surgery

A4S
Start date: July 2009
Phase: Phase 3
Study type: Interventional

The study is planned to check the analgesic and anti-inflammatory properties of Atorvastatin in patients who will be undergoing abdominal surgery under spinal anesthesia. The investigators intend to monitor the analgesic requirements, the rate of wound healing and the inflammatory markers in this trial.